Disc Medicine (NASDAQ:IRON) reported quarterly losses of $(1.77) per share which missed the analyst consensus estimate of $(1.51) by 16.91 percent. This is a 98.88 percent decrease over losses of $(0.89) per share from the same period last year.
Disc Medicine (NASDAQ:IRON) reported quarterly losses of $(1.77) per share which missed the analyst consensus estimate of $(1.51) by 16.91 percent. This is a 98.88 percent decrease over losses of $(0.89) per share from the same period last year.
Comments